Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
J Surg Oncol
    November 2026
  1. NUNES-REIS AR, Paulinelli RR, Rahal RMS, Ribeiro LFJ, et al
    Oncoplastic Surgery Versus Total Breast Reconstruction in Locally Advanced and Multicentric Carcinomas. A Matched Comparative Cohort Study of Oncologic and Aesthetic Outcomes.
    J Surg Oncol. 2026;134:958-967.
    >> Share

  2. DONG G, Heisler A, Namazian S, Wareham C, et al
    Comparing Breast Aesthetics Using a Novel Validated Breast Aesthetic Scale: Standard Breast-Conserving Surgery Versus Oncoplastic Techniques.
    J Surg Oncol. 2026;134:895-903.
    >> Share

    October 2026
  3. MATHEWS AL, Piltin MA, Wing SE, Hamm NC, et al
    Repeat Breast Cancer Surgeries After Segmental Mastectomy Meaningfully Increase Long Term Healthcare Costs.
    J Surg Oncol. 2026 Oct 12. doi: 10.1002/jso.70419.
    >> Share

  4. LOMBARDO GAG, Marchica P, Musmarra I, Martino B, et al
    Comparative Outcomes of Kiss Latissimus Dorsi Flap Versus Extended Thoracoabdominal Hatchet Flap for Large Chest Wall Reconstruction: A Retrospective Cohort Study.
    J Surg Oncol. 2026;134:739-747.
    >> Share

    September 2026
  5. DEN J, Nelson N, Vaghjiani R, Suzanne Klimberg V, et al
    The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Peri- and Postmenopausal Breast Cancer Outcomes.
    J Surg Oncol. 2026 Sep 30. doi: 10.1002/jso.70411.
    >> Share

  6. ROUMANI H, Aydas O
    Breast-Conserving Therapy Versus Mastectomy in Estrogen Receptor-Positive Breast Cancer: A PAM50-Adjusted Survival Analysis.
    J Surg Oncol. 2026 Sep 25. doi: 10.1002/jso.70404.
    >> Share

  7. CHEN J, Gabay A, Hassan AM, Graziano FD, et al
    AI Risk Prediction Tools for Autologous Breast Reconstruction.
    J Surg Oncol. 2026;134:539-547.
    >> Share

  8. WAPNIR I, Allison KH, Pittman SM, Tsai J, et al
    Breast Fellows Forum: A Multidisciplinary Core Curriculum Model for Surgical Oncology Fellowships.
    J Surg Oncol. 2026;134:502-504.
    >> Share

  9. CORSO G, Vecchia C, Magnoni F, Polizzi A, et al
    Bilateral Prophylactic and Contralateral Risk-Reducing Mastectomy in Women With Germline CDH1 Pathogenic or Likely-Pathogenic Variants.
    J Surg Oncol. 2026;134:475-480.
    >> Share

  10. TOMALA J, Upadhyay N
    Comparative Analysis of CEM and Breast MRI: A Retrospective Study.
    J Surg Oncol. 2026;134:518-524.
    >> Share

    August 2026
  11. ABDULLA HA, Matthew M, Zaborowski AM, Rutherford CL, et al
    Assessment of the Impact of Chemotherapeutic 'Treatment Effect' on Oncological Outcomes in Initially Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Only After Neoadjuvant Chemotherapy.
    J Surg Oncol. 2026 Aug 10. doi: 10.1002/jso.70369.
    >> Share

  12. OTERO-ROMERO D, Carraminana-Nuno R, Arribas-Del-Amo D
    Sentinel Lymph Node Biopsy in Elderly Patients With Aggressive Breast Cancer Subtypes: Real-World Clinical Utility and Treatment Implications.
    J Surg Oncol. 2026 Aug 10. doi: 10.1002/jso.70364.
    >> Share

  13. GAUR KS, Conroy MM, Rein LE, Szabo A, et al
    Assessing Time to Surgery in Asian Women With Breast Cancer: A National Cancer Database Analysis.
    J Surg Oncol. 2026 Aug 10. doi: 10.1002/jso.70368.
    >> Share

  14. PROUSSALOGLOU EM, Ren Y, Fayanju OM, Blitzblau RC, et al
    Patient Out-of-Pocket Costs and Healthcare Utilization Related to Mastectomy vs Breast Conservation: A Claims-Based Study.
    J Surg Oncol. 2026;134:185-196.
    >> Share

    July 2026
  15. SANTORO CN, Day CN, Sturz-Ellis JL, Hieken TJ, et al
    Contralateral Prophylactic Mastectomy at the Time of Therapeutic Mastectomy for Local Recurrence of Breast Cancer: Influence of Genetic Testing and Other Factors.
    J Surg Oncol. 2026 Jul 21. doi: 10.1002/jso.70339.
    >> Share

  16. WILLIAMS T, Li MX, Fine KS, Melnick BA, et al
    Racial Differences in Breast Cancer Treatment and Information Access.
    J Surg Oncol. 2026 Jul 5. doi: 10.1002/jso.70304.
    >> Share

  17. KIM M, Bubberman JM, Wang J, Boe LA, et al
    The Impact of Time and Place on BREAST-Q REACT: A Multi-Institutional Examination.
    J Surg Oncol. 2026;134:31-40.
    >> Share

  18. GIVANT M, Friedman R, Fanning JE, Chen A, et al
    Superficial and Functional Imaging of the Posterior Upper Arm Pathway in the Healthy Population.
    J Surg Oncol. 2026;134:128-134.
    >> Share

    May 2026
  19. HENDIZADEH AN, Wen A, Guidi R, Ritz E, et al
    The Impact of Breast Reconstruction on Smoking Cessation Among Patients With Breast Cancer.
    J Surg Oncol. 2026 May 24. doi: 10.1002/jso.70284.
    >> Share

  20. BAUMRUCKER CC, Harris N, Aiello P, Whiting J, et al
    Outcomes After Intratumoral Delivery of Immunotherapy in Breast Cancer.
    J Surg Oncol. 2026 May 13. doi: 10.1002/jso.70287.
    >> Share

  21. LEE SH, Kohler A, Tingen J, King CA, et al
    Cost-Utility Analysis of Indocyanine Green Versus Methylene Blue for Sentinel Lymph Node Biopsy in Breast Cancer.
    J Surg Oncol. 2026 May 10. doi: 10.1002/jso.70278.
    >> Share

  22. PUIRAS T, Juhanoja E, Tamminen A
    Omission of Sentinel Lymph Node Biopsy in Breast Cancer: A Real-World Validation of the Patient Populations of the SOUND and INSEMA Trials.
    J Surg Oncol. 2026 May 6. doi: 10.1002/jso.70256.
    >> Share

  23. PEPIN A, Almeida ND, Fung-Kee-Fung S, Kassick M, et al
    Boost Approaches in Patients Undergoing Postoperative Radiotherapy.
    J Surg Oncol. 2026;133:773-784.
    >> Share

    April 2026
  24. WANG B, Liu S, Huang Z, Wang J, et al
    The Role of Primary Tumor Resection in De Novo Bone-Only Metastatic Breast Cancer: A Propensity Score-Matched Analysis.
    J Surg Oncol. 2026 Apr 29. doi: 10.1002/jso.70277.
    >> Share

  25. BIRSINE Z, Alkan O, Bukun HO, Nazli I, et al
    Does Surgical Timing After Neoadjuvant Anti-HER2 Therapy Affect Pathological Complete Response and Survival in HER2-Positive Breast Cancer? A Multicenter Retrospective Cohort Study.
    J Surg Oncol. 2026 Apr 23. doi: 10.1002/jso.70270.
    >> Share

  26. CRONIN JE, Aryanpour Z, Durden JA, Hunt SC, et al
    Identifying Breast Cancer Risk in Patients Undergoing Gender-Affirming Chest Masculinization Surgery.
    J Surg Oncol. 2026 Apr 23. doi: 10.1002/jso.70272.
    >> Share

  27. EL-GABALAWY R, Logan GS, Hebbard P, Sommer JL, et al
    An Interactive Preoperative Virtual Reality Intervention for Breast Cancer Patients Undergoing Oncological Surgery: A Feasibility and Pilot Randomized Clinical Trial.
    J Surg Oncol. 2026 Apr 23. doi: 10.1002/jso.70269.
    >> Share

    March 2026
  28. CAROCO TV, Reis J, Saraiva RP, Angelo MD, et al
    Efficacy of Aminocaproic Acid in Preventing Postoperative Hematoma in Breast Cancer Surgery: A Prospective Study.
    J Surg Oncol. 2026 Mar 23. doi: 10.1002/jso.70244.
    >> Share

  29. ALTUNDAG K
    Discordance Between Breast and Nodal Pathologic Response in Triple-Negative Breast Cancer: Methodological Considerations and Contemporary Implications.
    J Surg Oncol. 2026 Mar 16. doi: 10.1002/jso.70241.
    >> Share

  30. VIEIRA RADC, Coelho EG, Cunha JRD, Neto RC, et al
    Surgical Quality Indicators for Locally Advanced Breast Carcinoma: Suggestions From the Brazilian Society of Surgical Oncology.
    J Surg Oncol. 2026;133:249-258.
    >> Share

    February 2026
  31. CRISTOFALO MM, Maesaka JY, Pereira DA, Nobrega GB, et al
    Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Systematic Review of Breast and Node Pathologic Response.
    J Surg Oncol. 2026 Feb 15. doi: 10.1002/jso.70213.
    >> Share

    January 2026
  32. NGUYEN AT, Duckworth ED, Li RA, Galiano RD, et al
    Disparities in Breast Cancer Screening, Diagnosis, and Outcomes Among Vietnamese American Women: A Systematic Review.
    J Surg Oncol. 2026 Jan 14. doi: 10.1002/jso.70164.
    >> Share

  33. HICKEY A, De la Cruz Ku G, King C, Franco C, et al
    Do Racial and Income Disparities Exist in the Application of 21-Gene Recurrence Score?
    J Surg Oncol. 2026;133:16-30.
    >> Share

    December 2025
  34. ESGUEVA AJ, Tomatis M, Ponti A, Marotti L, et al
    Changing Practices in Axillary Surgery After Neoadjuvant Breast Cancer Therapy: Insights From the EUSOMA European Database.
    J Surg Oncol. 2025 Dec 18. doi: 10.1002/jso.70158.
    >> Share

  35. DE LA CRUZ KU G, Desai A, Ho I, King C, et al
    Post-Operative Outcomes Across the Levels of Oncoplastic Breast Surgery According to the American Society of Breast Surgeons Oncoplastic Surgery Definition and Classification System.
    J Surg Oncol. 2025;132:1307-1316.
    >> Share

    November 2025
  36. ALBUAINAIN RY, Althawadi R, Eid R, Abdulla HA, et al
    Oncological Outcomes of Omitting Axillary Surgery in Early Breast Cancer: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025 Nov 26. doi: 10.1002/jso.70145.
    >> Share

  37. AUBREY JM, Liefeld HR, Armstrong C, Levine A, et al
    Prospective Review of Practice Patterns in Breast Cancer Surgery Facilitates Rapid Practice Change, Reduced Clinical Variation, and Cost Savings.
    J Surg Oncol. 2025 Nov 16. doi: 10.1002/jso.70130.
    >> Share

  38. DA SILVA LFCM, Carneiro FP, Motoyama AB
    MicroRNA Expression in Breast Cancer Patients, an Integrative Review.
    J Surg Oncol. 2025 Nov 16. doi: 10.1002/jso.70132.
    >> Share

  39. WANG L, Zhou J, Zhao H
    Letter to the Editor: Comment on: "Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients".
    J Surg Oncol. 2025 Nov 6. doi: 10.1002/jso.70126.
    >> Share

  40. GOLDHABER NH, O'Keefe TJ, Longo L, Blair SL, et al
    Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis.
    J Surg Oncol. 2025;132:1011-1018.
    >> Share

  41. GHOSH K, Kuchta K, Alva D, Seth AK, et al
    Is Prepectoral Implant Reconstruction Associated With Better Physical Well-Being?
    J Surg Oncol. 2025;132:1071-1075.
    >> Share

    October 2025
  42. ALTUNDAG K
    Liquid Biopsy in Metastatic Breast Cancer: Adoption Lags Despite Growing Evidence.
    J Surg Oncol. 2025 Oct 10. doi: 10.1002/jso.70107.
    >> Share

  43. KIM M, Gilliland JL, Jiang CZ, Parnes MF, et al
    Sexual Health in Postmastectomy Breast Reconstruction Patients and Value of an Intervention: A Qualitative Study.
    J Surg Oncol. 2025;132:825-835.
    >> Share

  44. WANG X, Shao Z, Zhu H, Zhang Q, et al
    Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in China.
    J Surg Oncol. 2025;132:845-852.
    >> Share

    September 2025
  45. REDAELLI M, Steadman JA, Hoskin TL, Hieken TJ, et al
    Does RECIST 1.1 Predict Nodal Response to Neoadjuvant Chemo-Immunotherapy in Breast Cancer?
    J Surg Oncol. 2025 Sep 24. doi: 10.1002/jso.70096.
    >> Share

  46. ZHANG X, Chen Y, Wu Q, Yu Y, et al
    Safety Analysis of Omitting Radiotherapy After Breast-Conserving Surgery in Patients With Early-Stage Breast Cancer: A Meta-Analysis Based on Randomized Controlled Trials.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70091.
    >> Share

  47. NGUYEN AT, Li RA, Ontiveros NC, Adam TH, et al
    Utility of the Social Vulnerability Index in Addressing Breast Cancer Disparities: A Meta-Analysis.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70080.
    >> Share

  48. EPHRAIM R, Kar M, Sultania M, Naik S, et al
    Factors Influencing the Choice of Mastectomy Over Breast Conservation Surgery in Early Breast Cancer: A Prospective Qualitative Exploration of Patient Perspectives From India.
    J Surg Oncol. 2025 Sep 14. doi: 10.1002/jso.70088.
    >> Share

    August 2025
  49. BRABENDER DE, Griffiths A, Lu KA, Armstrong K, et al
    Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients.
    J Surg Oncol. 2025 Aug 21. doi: 10.1002/jso.70070.
    >> Share

  50. LIU P, Liu Y, Xie Y, Hu S, et al
    Potential of Combination of CE-MRI and Serum Her-2neu Extracellular Domain in Evaluating Effectiveness of Neoadjuvant Chemotherapy in Breast Cancer.
    J Surg Oncol. 2025 Aug 11. doi: 10.1002/jso.70058.
    >> Share

  51. KIM M, Bubberman J, Amakiri U, Kim YS, et al
    Culture Impacts Sexual Well-Being in Autologous Breast Reconstruction: A Multi-Continental Examination.
    J Surg Oncol. 2025;132:375-383.
    >> Share

  52. GABAY AJ, Chen J, Stern CS, Gibbons C, et al
    Predicting Breast Reconstruction Readmission, Reoperation, and Prolonged Length of Stay: A Machine Learning Approach.
    J Surg Oncol. 2025;132:345-353.
    >> Share

  53. LEVY J, Amakiri U, Shammas RL, Graziano FD, et al
    Longitudinal Modeling in Surgical Oncology Research: A Primer Examining Patient-Reported Outcomes.
    J Surg Oncol. 2025;132:294-307.
    >> Share

    July 2025
  54. SUPPAN I, Lundon D, Garg PK, Caballero C, et al
    Clinical Use of Liquid Biopsy in Metastatic Breast Cancer-An ESSO-EYSAC International Survey.
    J Surg Oncol. 2025 Jul 14. doi: 10.1002/jso.70045.
    >> Share

  55. WILLERT CB, Bidstrup P, Mellemkjaer L, Kalstrup J, et al
    Bilateral Risk-Reducing Mastectomy With Immediate Breast Reconstruction Lowers Concerns of Breast Cancer in Women With a High-Risk Genetic Predisposition for Breast Cancer Compared With a Radiological Imaging Surveillance Group.
    J Surg Oncol. 2025 Jul 9. doi: 10.1002/jso.70029.
    >> Share

  56. WAREHAM C, Bertaux B, Chahine E, Homsy C, et al
    Geographical Presence of Plastic Surgeons in Relation to Breast Surgeons in the United States for Breast Reconstruction.
    J Surg Oncol. 2025;132:22-27.
    >> Share

    June 2025
  57. FANNING JE, Chen A, Thomson S, Tillotson E, et al
    Epitrochlear and Humeral Lymph Nodes: A Biomarker for Deep Lymphatic Function and Implications for Breast Cancer-Related Lymphedema Risk.
    J Surg Oncol. 2025 Jun 24. doi: 10.1002/jso.70002.
    >> Share

  58. VARAGUR K, Ribaudo JG, Keller M, Fadell NR, et al
    Understanding Trends in Incidence and Management of Pregnancy-Associated Breast Cancer in a National Sample Using Claims Data.
    J Surg Oncol. 2025 Jun 19. doi: 10.1002/jso.70010.
    >> Share

  59. VASCONCELOS CS, Salgado MRT, Martins MR, Anunciacao CEC, et al
    Soluble sFas, sFasL, sPD1, and sPDL1 Analyses in the Peripheral Blood of Locally Advanced Breast Cancer Patients Before and After Neoadjuvant Chemotherapy.
    J Surg Oncol. 2025 Jun 2. doi: 10.1002/jso.27723.
    >> Share

  60. COLEMAN-BELIN JC, Kim M, Graziano FD, Boe LA, et al
    Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing Affect Clinical and Patient-Reported Outcomes?
    J Surg Oncol. 2025;131:1400-1406.
    >> Share

  61. STERN CS, Shammas RL, Montes ES, Boe LA, et al
    Improving the Evaluation of Aesthetic Outcomes in DIEP Flap Breast Reconstruction: Validation of the Aesthetic Grading Tool.
    J Surg Oncol. 2025;131:1407-1412.
    >> Share

  62. HUANG A, Koesters E, Garza RM, Hanson SE, et al
    A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction.
    J Surg Oncol. 2025;131:1393-1399.
    >> Share

  63. NGUYEN A, Chon J, Coles B, Galiano R, et al
    Disparities in Breast Reconstruction After Mastectomy in Southeast Asia: A Systematic Review.
    J Surg Oncol. 2025;131:1601-1619.
    >> Share

    May 2025
  64. VAN DECAR SG, Barbera EL, Adams AM, Shore JM, et al
    A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System).
    J Surg Oncol. 2025 May 20. doi: 10.1002/jso.28159.
    >> Share

  65. DALY GE, Collins KL, Malone SE, Garreau J, et al
    Incidence of Deleterious Genetic Mutations in Newly Diagnosed Breast Cancer Patients Over the Age of 65: Is It Time to Expand Testing Parameters?
    J Surg Oncol. 2025 May 13. doi: 10.1002/jso.28151.
    >> Share

  66. CANO-LALLAVE E, Frutos-Bernal E, Anciones-Polo M, Serrano-Sanchez E, et al
    Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice.
    J Surg Oncol. 2025 May 13. doi: 10.1002/jso.28146.
    >> Share

  67. GRAZIANO FD, White DR, Plotsker EL, Shammas RL, et al
    Enhancing Patient Decision-Making in Breast Reconstruction: A Systematic Review of Decision Aid Efficacy.
    J Surg Oncol. 2025;131:1222-1235.
    >> Share

  68. ZINDANI S, Khalil M, Rashid Z, Altaf A, et al
    Association of Socio-Environmental Burden and Inequality With Cancer Screening and Mortality.
    J Surg Oncol. 2025;131:1110-1117.
    >> Share

  69. KIEFER J, Paidisetty P, Elmorsi RAI, Nguyen CHM, et al
    Contemporary Trends in Reconstruction for Patients With Sarcoma of the Breast.
    J Surg Oncol. 2025;131:1013-1023.
    >> Share

  70. GRAZIANO FD, Amakiri UO, Levy J, Shammas RL, et al
    Perioperative Venous Thromboembolism Chemoprophylaxis Does Not Increase Risk of Complications in Free Flap Breast Reconstruction.
    J Surg Oncol. 2025;131:1211-1221.
    >> Share

    April 2025
  71. DAVE N, Hajj JP, Ahmed S, Hulsman L, et al
    Immediate Breast Reconstruction for Inflammatory Breast Carcinoma: A Scoping Review.
    J Surg Oncol. 2025;131:775-781.
    >> Share

    March 2025
  72. CHIU CW, Su CM, Liao LM, Su CS, et al
    Upstaging Prediction Model to Guide the Application of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ: A Retrospective Comparative Study.
    J Surg Oncol. 2025;131:571-579.
    >> Share

    February 2025
  73. CLARK P, DiPasquale A, Cocco D, Brown A, et al
    Oncoplastic Surgery: Where Are We Now?
    J Surg Oncol. 2025;131:124-132.
    >> Share

  74. MCADAMS CD, Clevenger N, Nicholson K, Pesce C, et al
    Proportion of Patients With Ductal Carcinoma In Situ That Qualify for Observation Criteria Set Forth by Clinical Trials.
    J Surg Oncol. 2025;131:115-123.
    >> Share

  75. LEFF DR
    Technologies and techniques to improve precision in breast conserving surgery.
    J Surg Oncol. 2025;131:108-114.
    >> Share

    January 2025
  76. DE LA CRUZ KU G, Desai A, Hickey A, Valcarcel B, et al
    Disparities in Triple Negative Breast Cancer Among Hispanic Population Living in Latin America Versus the United States.
    J Surg Oncol. 2025 Jan 13. doi: 10.1002/jso.28088.
    >> Share

    December 2024
  77. ARREY EN, GoPaul D, Anderson D, Okoli J, et al
    Addressing Breast Cancer Disparities: A Comprehensive Approach to Health Equity.
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28011.
    >> Share

  78. WANG X, Jin J, Zhu Y, Liu X, et al
    Letter to "Body Mass Index and Breast Cancer-Related Lymphedema: A Retrospective Cohort Study".
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28055.
    >> Share

  79. LI F, Wei Y, Li L, Chen F, et al
    Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28046.
    >> Share

  80. NAJAFALI D, Siotos C, Kokosis G
    Taxanes and Breast Cancer-Related Lymphedema.
    J Surg Oncol. 2024 Dec 15. doi: 10.1002/jso.28017.
    >> Share

    November 2024
  81. NGUYEN A, Duckworth E, Pascua D, Coles B, et al
    Disparities in Breast Cancer Treatment and Reconstruction Among Native Hawaiian and Pacific Islander Women: Systematic Review and Meta-Analysis.
    J Surg Oncol. 2024 Nov 25. doi: 10.1002/jso.27994.
    >> Share

  82. HANNOUN-LEVI JM, Polgar C, Strnad V, Gutierrez C, et al
    With Regard to Schwieger L. et al. Intraoperative Radiation Therapy for Early-Stage Breast Cancer. DOI: 101002/jso27814.
    J Surg Oncol. 2024 Nov 11. doi: 10.1002/jso.27971.
    >> Share

    October 2024
  83. MCSHANE N, Zaborowski A, O'Reilly M, McCartan D, et al
    Hormone Receptor Positive Breast Cancer in Young Women: A Review.
    J Surg Oncol. 2024 Oct 29. doi: 10.1002/jso.27963.
    >> Share

  84. JIANG Q, Hu H, Liao J, Duan P, et al
    Body Mass Index and Breast Cancer-Related Lymphedema: A Retrospective Cohort Study.
    J Surg Oncol. 2024 Oct 28. doi: 10.1002/jso.27969.
    >> Share

  85. HANSSEN D, Champion N, Ngo J, Palfi S, et al
    Frailty and Malnutrition in Surgical Outcomes of Elderly Breast Cancer Patients.
    J Surg Oncol. 2024 Oct 10. doi: 10.1002/jso.27940.
    >> Share

  86. LIU C, Zhao H, Zhou Y
    Comment On: "Factors Influencing Prophylactic Surgical Intervention in Women With Genetic Predisposition for Breast Cancer".
    J Surg Oncol. 2024 Oct 8. doi: 10.1002/jso.27930.
    >> Share

    September 2024
  87. ALTUNDAG K
    The Association of Taxanes With Breast Cancer-Related Lymphedema.
    J Surg Oncol. 2024 Sep 19. doi: 10.1002/jso.27906.
    >> Share

  88. KU GC, Wareham C, King C, Koul A, et al
    Is Oncoplastic Surgery Safe in High-Risk Breast Cancer Phenotypes?
    J Surg Oncol. 2024 Sep 16. doi: 10.1002/jso.27899.
    >> Share

  89. ZHAO H, Xu J, Zhou Y
    Comment On: "Assessing Breast Cancer-Related Lymphedema Screening and Treatment Gaps in a Safety-Net Hospital".
    J Surg Oncol. 2024 Sep 9. doi: 10.1002/jso.27894.
    >> Share

  90. HUMAR P, Balogun Z, Douglas N, Glenney A, et al
    Factors influencing prophylactic surgical intervention in women with genetic predisposition for breast cancer.
    J Surg Oncol. 2024 Sep 1. doi: 10.1002/jso.27817.
    >> Share

  91. SELBY LV, Clark E, Chen JL, Tinoco G, et al
    Use of neoadjuvant paclitaxel in breast angiosarcoma-Impact on surgical resection and response rates.
    J Surg Oncol. 2024;130:579-585.
    >> Share

    August 2024
  92. SCHWIEGER L, Switchenko JM, Cao Y, Amaniera I, et al
    Intraoperative radiation therapy for early-stage breast cancer.
    J Surg Oncol. 2024 Aug 29. doi: 10.1002/jso.27814.
    >> Share

  93. SIOTOS C, Arnold SH, Seu M, Lunt L, et al
    Breast cancer-related lymphedema: A comprehensive analysis of risk factors.
    J Surg Oncol. 2024 Aug 27. doi: 10.1002/jso.27841.
    >> Share

  94. ALTUNDAG K
    Women with breast cancer who have second primary malignancies: Further information is still needed.
    J Surg Oncol. 2024 Aug 9. doi: 10.1002/jso.27809.
    >> Share

  95. STEADMAN JA, Hieken TJ
    Advances from targeted therapy for non-metastatic HER2-positive inflammatory breast cancer.
    J Surg Oncol. 2024 Aug 5. doi: 10.1002/jso.27797.
    >> Share

  96. LOU Y, Qu M
    Letter to the Editor: Comment on: "Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology".
    J Surg Oncol. 2024;130:347-348.
    >> Share

  97. YANG AZ, Hyland CJ, Miller AS, Killelea BK, et al
    Local practice variations and payer differences underlie state-wide disparities in oncoplastic breast surgery.
    J Surg Oncol. 2024;130:210-221.
    >> Share

  98. DAUNGSUPAWONGM H, Wiwanitkit V
    Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology: Correspondence.
    J Surg Oncol. 2024;130:338.
    >> Share

  99. ROLDAN-VASQUEZ E, Mitri S, Bhasin S, Bharani T, et al
    Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology.
    J Surg Oncol. 2024;130:188-203.
    >> Share

    July 2024
  100. CHEN C, Tseng J, Amersi F, Silberman AW, et al
    Second primary malignancies in women with breast cancer.
    J Surg Oncol. 2024 Jul 19. doi: 10.1002/jso.27785.
    >> Share

  101. GARAYUA-CRUZ L, Broida SE, Okuno SH, Robinson SI, et al
    Outcomes of non-angiosarcoma radiation-associated soft tissue sarcomas of the chest.
    J Surg Oncol. 2024;130:56-63.
    >> Share

  102. UPADHYAY N, Wolska J
    Imaging the dense breast.
    J Surg Oncol. 2024;130:29-35.
    >> Share

  103. BOLAND MR
    Modern management of the axilla.
    J Surg Oncol. 2024;130:23-28.
    >> Share

    June 2024
  104. HYAMS DM, Bareket-Samish A, Rocha JEB, Diaz-Botero S, et al
    Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays.
    J Surg Oncol. 2024 Jun 24. doi: 10.1002/jso.27692.
    >> Share

  105. KELLEY K, Sener SF
    Who still needs surgical staging of the axilla for invasive breast cancer?
    J Surg Oncol. 2024 Jun 21. doi: 10.1002/jso.27753.
    >> Share

  106. YOUNG S, Geary A, Zhao X, Kenzik K, et al
    Assessing breast cancer-related lymphedema screening and treatment gaps in a safety-net hospital.
    J Surg Oncol. 2024 Jun 14. doi: 10.1002/jso.27735.
    >> Share

  107. SALGADO MRT, Sobral DV, Martins MR, Salgado EFMT, et al
    Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple-negative breast cancer.
    J Surg Oncol. 2024 Jun 6. doi: 10.1002/jso.27725.
    >> Share

  108. SOBRAL DV, Salgado MRT, Martins MR, Vasconcelos CS, et al
    Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24(neg) cells in the locally advanced and metastatic breast cancer.
    J Surg Oncol. 2024 Jun 2. doi: 10.1002/jso.27716.
    >> Share

  109. CHEN JC, Handley D, Elsaid MI, Fisher JL, et al
    Racial disparities in disease-specific mortality and surgical management of patients with ductal carcinoma in situ with microinvasion.
    J Surg Oncol. 2024;129:1179-1186.
    >> Share

  110. AMBIKA M, Lara S, Faulkner HR, Toncred S, et al
    Oncoplastic reconstruction with breast-conserving treatment versus breast-conserving treatment alone in the elderly.
    J Surg Oncol. 2024;129:1187-1191.
    >> Share

  111. KIM M, Vingan P, Boe LA, Tadros AB, et al
    Nonresponse data in sexual well-being among breast reconstruction patients-who are we overlooking?
    J Surg Oncol. 2024;129:1192-1201.
    >> Share

  112. REYES-MONASTERIO A, Moller MG, Lozada-Martinez ID, Narvaez-Rojas AR, et al
    Bridging frontiers: The role of a Global Breast Research Working Group.
    J Surg Oncol. 2024;129:1507-1514.
    >> Share

  113. KIM M, Ali B, Graziano FD, Colvin K, et al
    Analyzing mastectomy and reconstruction weight in immediate autologous breast reconstruction: A preliminary study.
    J Surg Oncol. 2024;129:1466-1474.
    >> Share

    May 2024
  114. DI PACE B, Padley RH
    Enhancing treatment compliance in breast cancer patients: A multi-faceted approach.
    J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27679.
    >> Share

  115. DI PACE B, Padley RH
    Breast cancer survivorship: A viewpoint.
    J Surg Oncol. 2024 May 19. doi: 10.1002/jso.27680.
    >> Share

  116. KEATING N, Cevik J, Hopkins D, Lippey J, et al
    Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
    J Surg Oncol. 2024;129:1025-1033.
    >> Share

  117. SPIEKERMAN VAN WEEZELENBURG MA, Daemen JHT, van Kuijk SMJ, van Haaren ERM, et al
    Seroma formation after mastectomy: A systematic review and network meta-analysis of different flap fixation techniques.
    J Surg Oncol. 2024;129:1015-1024.
    >> Share

  118. DI PACE B, Padley RH
    Survivorship and breast cancer: Navigating the continuum of care.
    J Surg Oncol. 2024 May 1. doi: 10.1002/jso.27671.
    >> Share

    April 2024
  119. ABAHSSAIN H, Souadka A
    Navigating the complexity of post-NAT therapy in breast cancer: The role of ctDNA testing.
    J Surg Oncol. 2024 Apr 23. doi: 10.1002/jso.27658.
    >> Share

  120. NTOWE KW, Lee MS, Plichta JK
    Clinical genetics in breast cancer.
    J Surg Oncol. 2024 Apr 1. doi: 10.1002/jso.27630.
    >> Share

  121. SPIEKERMAN VAN WEEZELENBURG MA, de Rooij L, Aldenhoven L, van Kuijk SMJ, et al
    Drain-free mastectomy and flap fixation: The interim analysis of a randomized controlled noninferiority trial.
    J Surg Oncol. 2024;129:975-980.
    >> Share

    March 2024
  122. VALENTE S, Roesch E
    Breast cancer survivorship.
    J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27627.
    >> Share

    December 2023
  123. ROCHLIN DH, Matros E, Shamsunder MG, Rubenstein R, et al
    Plastic surgery market share of breast reconstructive procedures: An analysis of two nationwide databases.
    J Surg Oncol. 2023;128:1064-1071.
    >> Share

  124. DE LA CRUZ KU G, Camarlinghi M, Mallouh MP, Torres-Roman JS, et al
    The impact of body mass index on oncoplastic breast surgery: A multicenter analysis.
    J Surg Oncol. 2023;128:1052-1063.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016